CRNC vs. EDIT

Last updated Jul 11, 2026

CRNC (Cerence Inc.) and EDIT (Editas Medicine, Inc.) are both stocks. CRNC operates in Software - Application (Technology), while EDIT operates in Biotechnology (Healthcare). Over the past 5 years, CRNC returned -38.01%/yr vs -41.74%/yr for EDIT. At a 0.36 correlation, their price movements are largely independent.

Performance

CRNC vs. EDIT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cerence Inc. (CRNC) and Editas Medicine, Inc. (EDIT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CRNC achieves a -2.06% return, which is significantly lower than EDIT's 59.02% return.

CRNC

• 1D: 0.10%
• 1M: -1.41%
• 6M: -15.22%
• YTD: -2.06%
• 1Y: 12.22%
• 3Y*: -28.36%
• 5Y*: -38.01%
• 10Y*: —

EDIT

• 1D: -1.21%
• 1M: 30.40%
• 6M: 57.49%
• YTD: 59.02%
• 1Y: 13.19%
• 3Y*: -28.58%
• 5Y*: -41.74%
• 10Y*: -18.64%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CRNC vs. EDIT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
CRNC Cerence Inc.	-2.06%	36.18%	-60.07%	6.10%	-75.82%	-23.73%	344.01%	31.65%
EDIT Editas Medicine, Inc.	59.02%	61.42%	-87.46%	14.21%	-66.59%	-62.13%	136.78%	34.35%

Correlation

The correlation between CRNC and EDIT is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.27
Correlation (3Y) Calculated over the trailing 3-year period	0.32
Correlation (5Y) Calculated over the trailing 5-year period	0.37
Correlation (All Time) Calculated using the full available price history since Oct 2, 2019	0.36

Fundamentals

Market Cap CRNC : $473.12M EDIT : $319.15M
EPS CRNC : -$0.44 EDIT : -$1.18
PS Ratio CRNC : 1.56 EDIT : 8.38
PB Ratio CRNC : 3.10 EDIT : 72.39
Total Revenue (TTM) CRNC : $302.14M EDIT : $35.86M
Gross Profit (TTM) CRNC : $235.95M EDIT : $35.86M
EBITDA (TTM) CRNC : $34.08M EDIT : -$76.66M

Return for Risk

CRNC vs. EDIT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRNC

CRNC Risk / Return Rank: 50
CRNC Sharpe Ratio Rank: 48
CRNC Sortino Ratio Rank: 54
CRNC Omega Ratio Rank: 52
CRNC Calmar Ratio Rank: 49
CRNC Martin Ratio Rank: 49

EDIT

EDIT Risk / Return Rank: 50
EDIT Sharpe Ratio Rank: 48
EDIT Sortino Ratio Rank: 55
EDIT Omega Ratio Rank: 52
EDIT Calmar Ratio Rank: 48
EDIT Martin Ratio Rank: 48

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRNC vs. EDIT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cerence Inc. (CRNC) and Editas Medicine, Inc. (EDIT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CRNC	EDIT	Difference
Sharpe ratio: Return per unit of total volatility	0.08	0.07	+0.01
Sortino ratio: Return per unit of downside risk	0.78	0.83	-0.06
Omega ratio: Gain probability vs. loss probability	1.09	1.10	0.00
Calmar ratio: Return relative to maximum drawdown	0.13	0.11	+0.02
Martin ratio: Return relative to average drawdown	0.26	0.19	+0.07

CRNC vs. EDIT - Sharpe Ratio Comparison

The current CRNC Sharpe Ratio is 0.08, which is comparable to the EDIT Sharpe Ratio of 0.07. The chart below compares the historical Sharpe Ratios of CRNC and EDIT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

CRNC vs. EDIT - Drawdown Comparison

The maximum CRNC drawdown since its inception was -98.22%, roughly equal to the maximum EDIT drawdown of -98.92%. Use the drawdown chart below to compare losses from any high point for CRNC and EDIT.

Drawdown Indicators

	CRNC	EDIT	Difference
Max Drawdown Largest peak-to-trough decline	-98.22%	-98.92%	+0.70%
Max Drawdown (1Y) Largest decline over 1 year	-55.92%	-59.88%	+3.96%
Max Drawdown (3Y) Largest decline over 3 years	-91.48%	-91.18%	-0.30%
Max Drawdown (5Y) Largest decline over 5 years	-98.02%	-98.66%	+0.64%
Max Drawdown (10Y) Largest decline over 10 years	—	-98.92%	—
Current Drawdown Current decline from peak	-92.15%	-96.40%	+4.25%
Average Drawdown Average peak-to-trough decline	-63.44%	-62.87%	-0.57%
Ulcer Index Depth and duration of drawdowns from previous peaks	27.13%	34.83%	-7.70%

Volatility

CRNC vs. EDIT - Volatility Comparison

The current volatility for Cerence Inc. (CRNC) is 20.25%, while Editas Medicine, Inc. (EDIT) has a volatility of 24.22%. This indicates that CRNC experiences smaller price fluctuations and is considered to be less risky than EDIT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CRNC	EDIT	Difference
Volatility (1M) Calculated over the trailing 1-month period	20.25%	24.22%	-3.97%
Volatility (6M) Calculated over the trailing 6-month period	59.52%	64.27%	-4.75%
Volatility (1Y) Calculated over the trailing 1-year period	85.62%	92.66%	-7.04%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	113.80%	93.71%	+20.09%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	106.16%	83.96%	+22.20%

Dividends

CRNC vs. EDIT - Dividend Comparison

Neither CRNC nor EDIT has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both CRNC and EDIT in my portfolio?

CRNC and EDIT have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CRNC or EDIT?

EDIT has higher volatility (24.22%) compared to CRNC (20.25%). In terms of maximum drawdown, CRNC dropped -98.22% vs EDIT's -98.92%.

Which has better risk-adjusted returns?

CRNC currently has the higher Sharpe Ratio (0.08 vs 0.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.